Message Font: Serif | Sans-Serif
No. of Recommendations: 0
DNAPrint genomics is a 1+ year old startup company headed by Tony Frudakis, Ph.D. (formerly of Corixa; CRXA) based in Florida. They recently released this news about presenting at the Genome Sequencing and Analysis Conference (GSAC) conference in San Diego:

At the conference today (10/27/01) they announced that a major part of their first product, Retinome, has passed its initial testing and that they have developed the capability of determining shade of eye color from a DNA sample. They are working on skin and hair color as well. This has major implications in forensic science. They are planning a press release on Monday to make this public. This is not their only product in the pipeline and they suggest that other projects are nearing completion. Do your DD:

They currently have a market cap of about $ 40+ million with ~400,000,000 shares @ $0.115 per share. Recently they have been as low as 0.039. They have one of the most active boards on Raging Bull:

Because of the large number of shares, they aren't as volatile as some other pennies, but they do have potential.

Adenovir (same handle on Raging Bull)
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.